Protective role of vitamin D status against COVID-19: a mini-reviewReview Published on 2023-02-012023-07-10 Journal: Endocrine [Category] COVID19(2023년), [키워드] COVID-19 Cytokines immune system respiratory vitamin D. [DOI] 10.1007/s12020-022-03203-8 PMC 바로가기 [Article Type] Review
Clinical Manifestations of MonkeypoxReview Published on 2023-01-012023-06-09 Journal: Advances in experimental medicine and biology [Category] 원숭이두창, [키워드] dermatological Monkeypox neurological respiratory signs Symptoms. [DOI] 10.1007/5584_2022_747 PMC 바로가기 [Article Type] Review
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends DataArticle Published on 2022-12-212023-07-11 Journal: Journal of Medical Internet Research [Category] COVID19(2023년), [키워드] children COVID-19 Google Google Trends Health Infection Intervention pandemic pharmaceutical respiratory respiratory syncytial virus RSV search engine virus. [DOI] 10.2196/42781 PMC 바로가기
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variantsCoronVac 백신 3차 접종은 SARS-CoV-2 Delta 및 Omicron 변이체를 인식하는 광범위하고 강력한 적응 면역 반응 유도Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive Adaptive immune response B cell B cells boost booster booster dose booster vaccination CD4 CD8 Cell circulating comparable contagious CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Delta demonstrated detectable domain dose effective elevated elicited fold follicular healthy subject helper T cell Humoral immunity IgA responses immune responses Inactivated vaccine individual induce memory B memory B cell memory B cells neutralization neutralization activities neutralization activity neutralization. neutralizing activities omicron Omicron variants peaked predominant preserved Protein RBD receiving recognize reduced remained respiratory response SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 variant significantly increased spike-specific IgG strain subpopulations sustained T cell T cell responses T cells T cells response vaccination variant variants VOCs [DOI] 10.1080/22221751.2022.2081614 PMC 바로가기 [Article Type] Article
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 eraArticle Published on 2022-12-012022-11-15 Journal: Microbiological research [Category] COVID19(2023년), SARS, 치료제, [키워드] acute respiratory syndrome against SARS-CoV AMP AMPs antimicrobial antimicrobial agent antimicrobial peptide antimicrobial resistance Antiviral antiviral agent antiviral peptides caused Compound coronavirus coronavirus 2 COVID-19 COVID-19 pandemic drug resistance effective Effectiveness highlight highly pathogenic life-threatening mechanism microbial infections peptide respiratory SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome coronavirus. therapeutic drug therapeutic strategy Treatment variety viral infection virus [DOI] 10.1016/j.micres.2022.127206 PMC 바로가기
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022Article Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory infections acute respiratory syndrome age caused changes in children circulation clinical information collected complete blood count coronavirus disease cough country COVID-19 COVID-19 outbreak COVID-19 pandemic described distribution emerging disease had no highlight hospital Hospitalization Hospitalized impacted Infection Influenza influenza virus influenza viruses Iran lockdown majority male medical condition Nasopharyngeal swab notable outbreak Outbreak. pandemic parameter pathogen Patient patients performed polymerase chain Precaution proportion Real-time PCR reported respiratory respiratory syncytial virus respiratory virus Result risk factor RSV SARS-CoV-2 subject tested threat Transmission viral genome virus virus [DOI] 10.1002/jmv.28065 PMC 바로가기
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants코로나바이러스 질병 재조합 소단위 백신의 세 번째 용량으로 이종 부스팅은 다양한 중증 급성 호흡기 증후군 코로나바이러스 2 변이체에 대한 중화 항체 및 T 세포 면역을 증가시킵니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis Anti-RBD IgG anti-S booster vaccination CD4+ T cell components composite pattern coronavirus coronavirus disease COVID-19 COVID-19 vaccinations COVID-19 vaccine dose effective epitope Epitopes evaluated Evidence help Heterologous heterologous boosting homologous Humoral immunity Immune escape Immunity immunization strategy immunological in some inactivated Inactivated vaccine increase magnitude NAb NAbs natural infection Neutralizing Neutralizing antibodies neutralizing antibody neutralizing capacity omicron pandemic prime-boost strategy produced RBD IgG respiratory subunit Subunit vaccine Subunit vaccine. T cell T cell response T cells titre vaccination Vaccination strategies Vaccination strategy Vaccine Vaccine-induced immunity variant variants of concern waned [DOI] 10.1080/22221751.2022.2048969 PMC 바로가기 [Article Type] Article
Influenza and other respiratory viruses in children: prevalence and clinical featuresArticle Published on 2022-12-012022-11-15 Journal: European Journal of Clinical Microbiology & Infect [Category] 신종인플루엔자, 진단, 치료기술, [키워드] age ARI Asthma clinical feature clinical manifestation collected cough COVID-19 pandemic Epidemic Epidemics Epidemiology female H1N1 ICU Infection Influenza influenza A influenza B other respiratory virus Patient positive Prevalence prevalent real-time RT-PCR respiratory respiratory infection respiratory virus respiratory virus respiratory viruses rhinoviruses RNA extraction specimens study period surveillance. tested virus was performed [DOI] 10.1007/s10096-022-04515-3 PMC 바로가기
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice근육내 및 비강내 상동 프라임-부스트를 침팬지 아데노바이러스 기반 COVID-19 백신과 결합하면 마우스에서 강력한 체액성 및 세포성 면역 반응을 이끌어냅니다.Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Adenovirus adenovirus-based Adenovirus-vectored vaccine Administered antibody titres approach BALB/c mice booster Cellular immune response ChAdTS-S coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines cytokine decrease Efficacy elicit elicited evaluated followed by group highest homologous humoral IFN-γ IFN-γ ELISPOT IgA IgG immune immune responses immunogenicity intracellular cytokine staining intramuscular intramuscular vaccination intranasal intranasal. Meso Scale Discovery mice prime immunization priming protocol provide pseudovirus neutralizing antibody respiratory responsible SARS-CoV-2 serotype shown T-cell Response T-cell responses tested titre vaccination Vaccine variants vectored vaccine [DOI] 10.1080/22221751.2022.2097479 PMC 바로가기 [Article Type] Article